Lauren Santye, Assistant Editor

Employing proteogenomics helps identifies therapeutic targets in breast cancer.

Women given vitamin D3 and calcium supplements had a 30% lower risk of cancer.

Top news of the day from across the health care landscape.

Attendees at the 2017 Asembia Specialty Pharmacy Summit will feature a robust lineup of sessions to obtain pharmacy CE credits.

Under the ruling, Biogen secured Tecfidera exclusivity through 2028.

Top news of the day from across the health care landscape.

Findings may explain why some patients with cancer respond to immunotherapy while others do not.

After a prolonged court battle, Abu-Jamal will begin treatment for HCV in prison.

Novel drug delivery system steadily releases preventive HIV drugs over an extended period of time.

Second phase 3 study meets primary endpoint in improving lung cancer survival.

Deborah Michaelson, MS, RPh, vice president of Operations at Ardon Health, discusses how pharmacies can help patients overcome the cost of high co-pays to maintain specialty drug adherence.

Alecensa shows promise treating anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer.

Top news of the day from across the health care landscape.

Newly developed framework offers a common ground for specialty pharmacy stakeholders.

Sovaldi plus Harvoni approved to treat HCV in children ages 12 to 17.

Sovaldi plus Harvoni is the first direct-acting antiviral treatment approved for children and adolescents aged 12 to 17.

Dalfampridine is the only FDA-approved drug to aid walking in patients with MS.

Small molecule inhibition of PRMT1 may be an effective therapeutic strategy in pancreatic cancer.

Technique will help scientists develop an effective HIV vaccine.

Patients with MS have a high incidence of calcium phosphate stones and struvite stones, study finds.

Top news of the day from across the health care landscape.

Amgen’s 2017 Trends in Biosimilars report examines commercialization and distribution issues in the biosimilar space.

Legal challenges, drug shortages, and regulatory issues create hurdles for biosimilars in the US market.

Genetic variants influences the risk of MS and other autoimmune disorders.

Use of either surgery resulted in equivalent disease-free survival and no difference in overall survival.

Sheila Arquette, RPh, director of Pharmacy Services at Independent Health, discusses the impact of prior authorizations on specialty pharmacy.

Top news of the day from across the health care landscape.

Strategic partnership will advance the use of data in value-based care.

Poorer health outcomes found in perinatally HIV-infected youth.

Behavioral treatments may help reduce severity of symptoms for conditions such as Crohn’s disease.